The market size for hormones in dosage, excluding contraceptives and antibiotics, in Spain showed fluctuating trends from 2013 to 2023, ending at approximately $2.39 billion in 2023. Notably, the market experienced variations with some growth spurts, such as in 2018, but declined significantly between 2022 and 2023 with a negative year-on-year change of 2.61%. The five-year compound annual growth rate (CAGR) was -3.26%, indicating a downward trend.
Future trends to watch for include:
- Potential impact of healthcare policy changes on market dynamics.
- Technological advancements in hormone therapies that could drive demand.
- Market consolidation among key players and its effect on competition.
- Shifts in consumer preferences towards more natural hormone alternatives.
